Delivery Of Phosphorodiamidate Morpholino Antisense Oligomers In Cancer Cells

We have collected information about Delivery Of Phosphorodiamidate Morpholino Antisense Oligomers In Cancer Cells for you. Follow the links to find out details on Delivery Of Phosphorodiamidate Morpholino Antisense Oligomers In Cancer Cells.


Delivery of Phosphorodiamidate Morpholino Antisense ...

    https://www.researchgate.net/publication/26329896_Delivery_of_Phosphorodiamidate_Morpholino_Antisense_Oligomers_in_Cancer_Cells
    Delivery of Phosphorodiamidate Morpholino Antisense Oligomers in Cancer Cells Article in Methods in Molecular Biology 542:351-61 · February 2009 with 40 Reads How we measure 'reads'

Delivery of Phosphorodiamidate Morpholino Antisense ...

    https://link.springer.com/protocol/10.1007/978-1-59745-561-9_19
    Feb 24, 2009 · Devi G.R. (2009) Delivery of Phosphorodiamidate Morpholino Antisense Oligomers in Cancer Cells. In: Walther W., Stein U. (eds) Gene Therapy of Cancer. Methods in Molecular Biology™ (Methods and Protocols), vol 542.Author: Gayathri R. Devi

Intracellular Delivery Strategies for Antisense ...

    https://www.liebertpub.com/doi/abs/10.1089/108729000421448
    Jul 08, 2004 · Phosphorodiamidate morpholino oligomers (PMO) are a new generation of antisense oligomers with high specificity and efficacy. They inhibit translation of targeted mRNA by steric blockade. Different methods were evaluated for efficient delivery of PMO into the cells in culture.Author: Chandramallika Ghosh, Patrick L. Iversen

Delivery of phosphorodiamidate morpholino antisense ...

    http://europepmc.org/abstract/MED/19565912
    Jan 01, 2009 · Phosphorodiamidate morpholino oligomers (PMO), which have a neutral chemistry, are extensively being used as tools for selective inhibition of gene expression in cell culture models and are currently in human clinical trials.Author: Gayathri R. Devi

Aminoglycoside Enhances the Delivery of Antisense ...

    https://www.cell.com/molecular-therapy-family/nucleic-acids/fulltext/S2162-2531(19)30096-4
    Jun 07, 2019 · However, therapeutic applications of AOs remain limited, particularly because of the lack of efficient cellular delivery methods imperative for achieving efficacy. In this study, we investigated a few aminoglycosides (AGs) for their potential to improve the delivery of antisense phosphorodiamidate morpholino oligomer (PMO) both in vitro and in ...Author: Mingxing Wang, Bo Wu, Sapana N. Shah, Peijuan Lu, Qilong Lu

A Simple Method for Delivering Morpholino Antisense Oligos ...

    https://www.liebertpub.com/doi/10.1089/oli.1.1996.6.169
    Jan 30, 2009 · We report a simple and effective means for delivering Morpholino antisense oligos into the cytosol of cultured anchorage-dependent animal cells. ... Delivery of Phosphorodiamidate Morpholino Antisense Oligomers in Cancer Cells. ... HIV Tat Peptide Enhances Cellular Delivery of Antisense Morpholino Oligomers. Hong M. Moulton, Michelle C. Hase ...Author: Michael Partridge, Alexandra Vincent, Paula Matthews, John Puma, David Stein, James Summerton

c-MYC antisense phosphosphorodiamidate morpholino oligomer ...

    https://www.researchgate.net/publication/5753342_c-MYC_antisense_phosphosphorodiamidate_morpholino_oligomer_inhibits_lung_metastasis_in_a_murine_tumor_model
    c-MYC amplification and overexpression has been correlated with progression and chemotherapy resistance in lung cancer. AVI-4126, a neutral antisense phosphorodiamidate morpholino oligomer (PMO ...

Definition of phosphorodiamidate morpholino oligomer AVI ...

    https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phosphorodiamidate-morpholino-oligomer-avi-4126
    Phosphorodiamidate morpholino oligomer AVI-4126 binds to c-Myc mRNA and blocks its translation, which may result in the death of tumor cells overexpressing c-Myc. Differing from traditional antisense oligodeoxynucleotides (ODNs), neutrally charged PMOs are composed of subunits of nucleic acid bases linked to a synthetic backbone and, so, are ...

Depleting regulatory T cells with ... - Cancer Gene Therapy

    https://www.nature.com/articles/cgt201163
    Oct 14, 2011 · The synthetic antisense phosphorodiamidate morpholino oligomers ... Delivery of phosphorodiamidate morpholino antisense oligomers in cancer cells.Author: M. A. Morse, A. Hobeika, D. Serra, Katherine Aird, M. McKinney, A. Aldrich, T. Clay, D. Mourich, H. ...

Saponins as Natural Adjuvant for Antisense Morpholino ...

    https://www.cell.com/molecular-therapy-family/nucleic-acids/fulltext/S2162-2531(18)30018-0
    Mar 24, 2018 · Antisense oligonucleotide (AON) therapy for Duchenne muscular dystrophy has drawn great attention in preclinical and clinical trials, but its therapeutic applications are still limited due to inefficient delivery. In this study, we investigated a few saponins for their potential to improve delivery performance of an antisense phosphorodiamidate morpholino oligomer (PMO) both in vitro and in ...Author: Mingxing Wang, Bo Wu, Sapana N. Shah, Peijuan Lu, Qilong Lu

Searching for Delivery Of Phosphorodiamidate Morpholino Antisense Oligomers In Cancer Cells?

You can just click the links above. The data is collected for you.

Related Delivery Info